Human late memory CD8+ T cells have a distinct cytokine signature characterized by CC chemokine production without IL-2 production
- PMID: 19841187
- DOI: 10.4049/jimmunol.0902068
Human late memory CD8+ T cells have a distinct cytokine signature characterized by CC chemokine production without IL-2 production
Abstract
Late memory T cell skewing is observed in the setting of immune recovery after cord blood transplantation, and may be associated with inferior control of viral reactivation and cancers. Therefore, we sought to understand how late memory cells differ functionally from earlier stage memory T cells, and whether surface phenotypes associated with differentiation stages were predictably associated with functional signatures. Higher order cytokine flow cytometry allows characterization of human T cells based on complex phenotypic markers and their differential capacity to simultaneously secrete effector proteins, including cytokines and chemokines. We used 8-color, 10-parameter cytokine flow cytometry to characterize the functional activation of human late memory CD8(+) T cells defined by CD45RA and CD27 expression (CD27(-)CD45RA(+)). We assessed the 15 possible functional signatures of cells defined by production of IL-2, IFN-gamma, TNF-alpha, and MIP-1beta alone or in combination, following activation with Ags stimulating bypassing surface proteins (PMA:ionomycin) or through the TCR (e.g., viral Ags). Late memory CD8(+) T cells produced abundant amounts of CC chemokines (MIP-1beta, MIP-1alpha, and RANTES) but not IL-2. IL-2/IFN-gamma coproduction, characteristic of protective immune responses to viral infections, was absent in late memory CD8(+) T cells. These data demonstrate that functional cytokine signatures are predictably associated with CD8(+) maturation stages, and that the polarization of late memory CD8(+) T cells toward CC chemokine production and away from IL-2 production suggests a unique functional role for this subset.
Similar articles
-
IFN-gamma and IL-12 differentially regulate CC-chemokine secretion and CCR5 expression in human T lymphocytes.J Leukoc Biol. 2002 Oct;72(4):735-42. J Leukoc Biol. 2002. PMID: 12377943
-
MIP-1alpha, MIP-1beta, RANTES, and ATAC/lymphotactin function together with IFN-gamma as type 1 cytokines.Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):6181-6. doi: 10.1073/pnas.092141999. Epub 2002 Apr 23. Proc Natl Acad Sci U S A. 2002. PMID: 11972057 Free PMC article.
-
Distinctive calcineurin-dependent (FK506-sensitive) mechanisms regulate the production of the CC chemokines macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES vs IL-2 and TNF-alpha by activated human T cells.Cell Immunol. 1998 Dec 15;190(2):121-31. doi: 10.1006/cimm.1998.1411. Cell Immunol. 1998. PMID: 9878113
-
The expansion and maintenance of antigen-selected CD8(+) T cell clones.Adv Immunol. 2007;96:103-39. doi: 10.1016/S0065-2776(07)96003-4. Adv Immunol. 2007. PMID: 17981205 Review.
-
Analyzing T-cell responses to cytomegalovirus by cytokine flow cytometry.Hum Immunol. 2004 May;65(5):493-9. doi: 10.1016/j.humimm.2004.02.004. Hum Immunol. 2004. PMID: 15172449 Review.
Cited by
-
Polyfunctionality of a DKK1 self-antigen-specific CD8(+) T lymphocyte clone in lung cancer.Cancer Immunol Immunother. 2011 Aug;60(8):1119-25. doi: 10.1007/s00262-011-1055-x. Epub 2011 Jun 17. Cancer Immunol Immunother. 2011. PMID: 21681374 Free PMC article.
-
Combinatorial immunotherapeutic approaches to restore the function of anergic tumor-reactive cytotoxic CD8+ T cells.Hum Vaccin Immunother. 2016 Oct 2;12(10):2519-2522. doi: 10.1080/21645515.2016.1193277. Epub 2016 Jul 26. Hum Vaccin Immunother. 2016. PMID: 27459422 Free PMC article.
-
Antiviral Agents for Preventing Cytomegalovirus Disease in Recipients of Hematopoietic Cell Transplantation.Viruses. 2024 Aug 8;16(8):1268. doi: 10.3390/v16081268. Viruses. 2024. PMID: 39205242 Free PMC article.
-
The evolving art of hematopoietic stem cell transplantation: translational research in post-transplant immune reconstitution and immunosuppression.Immunol Res. 2013 Dec;57(1-3):140-50. doi: 10.1007/s12026-013-8461-4. Immunol Res. 2013. PMID: 24242818 Review.
-
No evidence for TSLP pathway activity in human breast cancer.Oncoimmunology. 2016 May 9;5(8):e1178438. doi: 10.1080/2162402X.2016.1178438. eCollection 2016 Aug. Oncoimmunology. 2016. PMID: 27622057 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials